Poynton, United Kingdom

Keith Oldham



Average Co-Inventor Count = 2.6

ph-index = 8

Forward Citations = 161(Granted Patents)


Location History:

  • Cheshire, GB (1984)
  • Cheadle, GB (1982 - 1989)
  • Poynton, GB (1993 - 1995)
  • Macclesfield, GB (2003 - 2007)

Company Filing History:


Years Active: 1982-2007

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: The Innovative Journey of Keith Oldham: A Pioneer in Therapeutic Compounds

Introduction

Keith Oldham, an accomplished inventor from Poynton, GB, has made significant contributions to the field of medicinal chemistry, holding an impressive 23 patents to his name. His inventive journey is marked by his focus on quinazoline compounds, which have potent applications in treating T cell mediated diseases.

Latest Patents

Among his recent innovations are two notable patents that highlight his work with quinazoline derivatives. The first patent concerns quinazoline compounds with therapeutic use, specifically aimed at preventing or treating T cell mediated diseases in warm-blooded animals. The derivatives of Formula (I) are detailed in the description, showcasing various meanings for m, R, Z, n, and R in their application. The second patent similarly delves into quinazoline derivatives, reinforcing his commitment to finding medical solutions for complex conditions through these compounds.

Career Highlights

Throughout his career, Oldham has had the opportunity to work with renowned organizations, including Imperial Chemical Industries Limited and ICI Pharma. His contributions to science and medicine have not only enriched the industry but have also facilitated advancements that impact health and wellness.

Collaborations

In his professional journey, Keith Oldham collaborated with distinguished coworkers, including Derrick F. Jones and Philip N. Edwards. Their combined expertise and innovative thinking fostered an environment conducive to groundbreaking research and development.

Conclusion

Keith Oldham stands as a beacon of innovation in the realm of therapeutic compounds, with his extensive patent portfolio demonstrating his dedication to improving medical treatments. As he continues to explore the potential of quinazoline derivatives, the impact of his work is felt across the medical community, offering hope and solutions for various diseases affecting warm-blooded animals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…